FAID is an annual Franco-American event at the MIT Media Lab which brings together scientists, companies, entrepreneurs and investors. It is a high-level event in the Boston area where researchers and companies have the opportunity to exchange views on a specific technological issue, start co-operative activities and develop business transactions with a transatlantic perspective. The goal of the program is to facilitate the development of innovation ties between France and America. Check it out.


Update: Professor Howard gave a talk this year – a video of the talk is here

Here’s a link to all of the talks at FAID 2016.


The topic of the 2016 edition is “Precision Medicine & New Technologies: Transforming Clinical Research”. This conference is organized by the Office for Science & Technology of the Embassy of France in the United States in collaboration with MIT and the Global Care Initiative, a consortium of 5 non-profit French research Carnot Institutes. The Office for Science and Technology is a team of professors, senior researchers and engineers, in Washington D.C., in Boston, MA, and five other locations in the United States. Its mission is to promote bilateral partnerships in science, technology and innovation. It has been organizing the FAID conference in Boston since 2002. www.france-science.org

GLOBAL CARE Initiative (GCi) is an outstanding consortium of 5 non- profit French research Carnot institutes dedicated to human health. The consortium operates as a one-stop-shop for life science companies and research organizations that seek R&D collaboration from basic research to the late clinical phases. GLOBAL CARE Initiative combines strong scientific expertise to unique technology platforms to propose an innovation-centered collaboration offer. The consortium has extensive experience of partnerships with major pharmaceutical, biotech and MedTech companies. The Carnot Institutes members of the consortium are: the Carnot Institute of the Institut Pasteur (infectious diseases), of the Institut Curie (cancers) and of the ICM* (CNS diseases), and the Carnot Institutes Voir et Entendre** (vision and audition diseases and rehabilitation) and CALYM*** (lymphoma).